http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-216985377-U

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c066e99a149d78d63a4db1751997568
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2021-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_666a50e070fd397593bec3d9c1f4239b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf35a309ed503fc81dc2d099d9df4a80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_262f62b26b7f5c80c565b27f3440a450
publicationDate 2022-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-216985377-U
titleOfInvention Foldable scleral cross-linking device and scleral cross-linking device
abstract The utility model relates to the technical field of ophthalmic medical instruments, in particular to a foldable sclera cross-linking device and a sclera cross-linking device. The foldable scleral cross-linking device of the present invention comprises: a foldable device body made of a first flexible material and a foldable light guide layer made of a second flexible material; The surface contacting the treatment part is configured as a treatment area; the light guide layer is arranged in the device body to irradiate the treatment light on the eye treatment part through the treatment area; a treatment cavity is arranged in the device body, and the treatment cavity is arranged in the light guide Between the layer and the treatment area, the treatment area is provided with a treatment hole communicated with the treatment cavity, and the treatment cavity is connected with the perfusion device, so that the treatment solution can be dripped on the eye treatment part through the treatment hole. The utility model has the advantages of small incision, accurate positioning, flexible operation and accurate quantification, and can realize accurate positioning and perform minimally invasive and precise scleral cross-linking operation.
priorityDate 2021-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426131764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7048776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291

Total number of triples: 21.